Latest Breaking News On - New york based regeneron - Page 1 : vimarsana.com

Regeneron Bets $100M That Mammoth's CRISPR Tech Can Deliver on Next Wave of Genetic Medicines

Pfizer gets $1.96 billion COVID medication order from Pentagon

The Pentagon has made a big $1.96 billion order from Pfizer Inc. for its COVID oral medication Paxlovid.

Regeneron captures new piece for cancer with $250M Checkmate Pharma buyout

Regeneron Pharmaceuticals is paying $250 million cash to acquire Checkmate Pharmaceuticals, a clinical-stage biotech developing drugs that activate the innate immune system. The biotech’s lead drug candidate is currently in pivotal testing in melanoma.

Dr. Christina Rahm warns that MORE bioweapons are coming after COVID

Cure the Causes founder Dr. Christina Rahm warned the public that more bioweapons are coming after the Wuhan coronavirus (COVID-19). Prior to delving into holistic medicine, Rahm worked for [...]

Regeneron's Covid Antibody Treatment Drives Surge in Sales

Regeneron's Covid Therapy Propels Strong Second-Quarter Growth

FDA authorizes Regeneron's Covid drug at lower dose, and in injectable formulation

Emergency authorization of Regeneron Pharmaceuticals’ Covid-19 antibody drug now includes an injectable version, which is a more convenient option for patients. The drug developer plans to seek full FDA approval of its antibody cocktail later this summer.

Regeneron, Roche injectable antibody drug shows efficacy in preventing Covid-19

Regeneron, Roche injectable antibody drug shows efficacy in preventing Covid-19 A Regeneron Pharmaceuticals antibody cocktail currently authorized for treating Covid-19 now has additional clinical data showing it reduces the risk of infection spread. The drug developer, along with partner Roche, plan to ask regulators to expand the drug’s authorization to include disease prevention. Shares0 A Covid-19 antibody cocktail developed by Regeneron Pharmaceuticals and Roche has pivotal clinical trial data showing it protected against the spread of infection among people in the same household. The results support use of the drug as a preventative measure in a formulation that’s easier for both physicians and patients.

Eli Lilly's authorized Covid-19 antibody racks up more positive Phase 3 data

Get the latest industry news first when you subscribe to our daily newsletter. We will never sell or share your information without your consent. See our privacy policy.

Eli Lilly's antibody combo for Covid-19 gets OK for emergency use

The EUA for Eli Lilly brings to patients a second antibody cocktail, following the FDA’s fall authorization of an antibody combination from Regeneron Pharmaceuticals. Lilly is working with Amgen to ramp up manufacturing of its newly authorized therapy.